Informação sobre produto
TAS0728 is an experimental drug that has potent antitumor activity and may be used for the treatment of cancer. TAS0728 does not have any known adverse effects on healthy cells, but it does have a potent effect on activated cardiac myocytes. TAS0728 has been shown to inhibit receptor-mediated signaling by blocking the epidermal growth factor (EGF) receptor, which may cause cancer resistance or growth factor. TAS0728 also blocks the epidermal growth factor (EGF), which can lead to cancer cell proliferation and increased tumor size. The powder diffraction spectrum of TAS0728 shows that it is composed of crystalline material with a molecular weight of 578.6 g/mol.
Propriedades químicas
Consulta técnica sobre: 3D-NID32316 TAS0728
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
